Galvin Roy 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Galvin Roy（CIK 1950021）在 1 家公司共报告 7 笔 SEC Form 4 内部人交易（最近一笔 2026-05-19）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Commercial Officer | 卖出 | 879 | $49,479 |
| 2026-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Commercial Officer | 买入 | 27,535 | $0 |
| 2025-11-03 | HAEMONETICS CORP (HAE) | EVP, Chief Commercial Officer | 卖出 | 145 | $7,251 |
| 2025-06-13 | HAEMONETICS CORP (HAE) | EVP, Chief Commercial Officer | 买入 | 5,689 | $0 |
| 2025-05-20 | HAEMONETICS CORP (HAE) | President, Global Plasma & BC | 买入 | 6,755 | $0 |
| 2025-05-19 | HAEMONETICS CORP (HAE) | President, Global Plasma & BC | 卖出 | 201 | $13,945 |
| 2025-05-19 | HAEMONETICS CORP (HAE) | President, Global Plasma & BC | 卖出 | 257 | $18,070 |
来源：SEC Form 4 申报文件 · 截至 2026-05-19